Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)

Since its spin-off from Pfizer ( PFE ) in 2012, the New Jersey-based Zoetis Inc. ( ZTS ) has become the most dominant pharmaceutical company engaged in animal health. Approximately 2/3 rd of its revenue isI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the key to creating wealth is ...